Five9, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Five9, Inc. on February 11, 2025. The filing addresses a corporate governance action regarding the extension of an executive compensation plan.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material change reported is the extension of the Five9, Inc. 2019 Key Employee Severance Benefit Plan (KESP). Originally set to expire on April 4, 2025, the Compensation Committee approved a two-year extension on February 11, 2025. The benefits provided under the extended plan remain identical to the terms previously in effect.
Plan Terms and Executive Coverage
The KESP provides severance benefits to senior executives based on their tier and the reason for termination:
- Termination without Cause (No Change in Control): Participants receive a lump sum cash payment ranging from 4 to 12 months of base salary and health insurance coverage for 4 to 12 months, depending on their tier.
- Termination in Connection with Change in Control: Participants receive a lump sum cash payment ranging from 6 to 18 months of base salary plus target annual bonus, health insurance coverage for 6 to 18 months, and full accelerated vesting of unvested equity awards.
- Golden Parachute Provisions: Payments are subject to reduction if they trigger excise taxes under Section 4999 of the Internal Revenue Code, provided the reduction results in a higher net after-tax benefit to the participant.
Named Executive Officers and Tiers:
- Michael Burkland (CEO): Tier 1
- Barry Zwarenstein (CFO): Tier 2
- Andy Dignan (COO): Tier 3
- Panos Kozanian (EVP, Product Engineering): Tier 3
Outlook and Risks
The filing does not provide updated financial guidance, management commentary on business outlook, or new risk factors. The extension of the severance plan is a routine administrative action to maintain existing executive retention and protection mechanisms.
Key Facts for Investor Verification
- The KESP extension was approved by the Compensation Committee after consultation with a compensation consultant.
- The extension adds two years to the plan's term, moving the expiration date to April 4, 2027.
- Benefit levels for all tiers remain unchanged from the original 2019 plan.
- Receipt of benefits is contingent upon the execution of a release of claims and compliance with restrictive covenants.